Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
VE202 consists of selected Clostridia strains shown to induce regulatory T cells in the colon, modulate mucosal immunity, and promote epithelial healing. The product is intended to counteract the dysbiosis and immune dysregulation that underlie UC, targeting disease at the microbiota-immune interface.
VE202 is an orally administered, live biotherapeutic product developed by Vedanta Biosciences, designed for the treatment of ulcerative colitis (UC). VE202 consists of a defined consortium of 16 strains of commensal gut bacteria, specifically selected for their potential to r…